Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

6.97
Delayed Data
As of Aug 25
 -0.02 / -0.29%
Today’s Change
5.93
Today|||52-Week Range
9.32
-13.42%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close6.99
Today’s open6.97
Day’s range6.93 - 6.97
Volume600
Average volume (3 months)3,493
Market cap$177.9M
Dividend yield--
Data as of 08/25/2016

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.24
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
PTGXProtagonist Therapeu...-0.23-2.10%
ENZYEnzymotec Ltd-0.04-0.51%
PFNXPfenex Inc-0.13-1.68%
OSIROsiris Therapeutics ...+0.08+1.61%
Data as of 08/25/2016

Financials

Next reporting dateNovember 16, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Assaf Kacen
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers

Search for Jobs